Enhancement of methyl methanesulfonate-induced base excision repair in the presence of selenomethionine on p53-dependent pathway

Journal of Medicinal Food

Volumn 12, Issue 2, 2009, Pages 340-344

  Jung, Hwa Jin ^a   Lee, Ju Han ^a   Seo, Young R ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Base excision repair; Chemoprevention; P53; Selenium

Indexed keywords

APURINIC ACID; MESYLIC ACID METHYL ESTER; PROTEIN P53; SELENOMETHIONINE;

ANTINEOPLASTIC ACTIVITY; APYRIMIDINIC SITE; ARTICLE; DNA DAMAGE; EXCISION REPAIR; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; OXIDATIVE STRESS; PRIORITY JOURNAL; WILD TYPE;

ANTIOXIDANTS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DNA DAMAGE; DNA REPAIR; GENE EXPRESSION; HUMANS; METHYL METHANESULFONATE; MUTATION; NUCLEAR PROTEINS; RNA, SMALL INTERFERING; SELENOMETHIONINE; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 67649540487     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2007.0709     Document Type: Article

References (31)

1. Ip C: Prophylaxis of mammary neoplasia by selenium supplementation in the initiation and promotion phases of chemical car-cinogenesis. Cancer Res 1981;41:4386-4390.
2. Shina R, Said TK, Medina D: Organic and inorganic selenium compounds inhibit mouse mammary cell growth in vitro by different cellular pathways. Cancer Lett 1996;107:277-284.
3. Lu J, Jiang C, Kaeck M, et al. : Dissociation of the genotoxic and growth inhibitory effects of selenium. Biochem Pharmacol 1995;50:213-219.
4. Ip C, el-Bayoumi K, Upadhyaya P, Ganther H, Vadhanavikit S, Thompson H: Comparative effect of inorganic and organic se-lenocyanate derivatives in mammary cancer chemoprevention. Carcinogenesis 1994;15:187-192.
5. Patterson BH, Levander OA: Naturally occurring selenium compounds in cancer chemoprevention trials: a workshop summary. Cancer Epidemiol Biomarkers Prev 1997;6:63-69.
6. Stewart MS, Spallholz JE, Neldner KH, Pence BC: Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic Biol Med 1999;26:42-48.
7. Clark LC, Combs GF Jr, Turnbull BW, et al. : Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996;276:1957-1963.
8. Heinonen OP, Albanes D, Huttunen JK, et al. : Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998;90:440-446.
9. Seo YR, Kelley MR, Smith ML: Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc Natl Acad Sci U S A 2002;99:14548-14553.
10. Ko LJ, Prives C: p53: puzzle and paradigm. Genes Dev 1996;10: 1054-1072.
11. Giaccia AJ, Kastan MB: The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 1998;12: 2973-2983.
12. Prives C, Hall PA: The p53 pathway. J Pathol 1999;187:112-126.
13. Lane DP: Cancer. p53, guardian of the genome. Nature 1992;358: 15-16.
14. Liebermann DA, Hoffman B, Steinman RA: Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 1995;11:199-210.
15. Hwang BJ, Ford JM, Hanawalt PC, Chu G: Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc Natl Acad Sci U S A 1999;96: 424-428.
16. Jung HJ, Kim EH, Mun JY, et al. : Base excision DNA repair defect in Gadd45a-deficient cells. Oncogene 2007;26:7517-7525.
17. Seo YR, Sweeney C, Smith ML: Selenomethionine induction of DNA repair response in human fibroblasts. Oncogene 2002;21: 3663-3669.
18. Fischer JL, Lancia JK, Mathur A, Smith ML: Selenium protection from DNA damage involves a Ref1/p53/Brca1 protein complex. Anticancer Res 2006;26:899-904.
19. Fischer JL, Mihelc EM, Pollok KE, Smith ML: Chemotherapeu-tic selectivity conferred by selenium: a role for p53-dependent DNA repair. Mol Cancer Ther 2007;6:355-361.
20. Klein EA, Lippman SM, Thompson IM, et al. : The selenium and vitamin E cancer prevention trial. World J Urol 2003;21:21-27.
21. Alan CB, Lacourciere GM, Stadtman TC: Responsiveness of se-lenoproteins to dietary selenium. Annu Rev Nutr 1999;19:1-16.
22. Bedwal RS, Nair N, Sharma MP, Mathur RS: Selenium - its biological perspectives. Med Hypotheses 1993;41:150-159.
23. Ip C, Thompson HJ, Zhu Z, Ganther HE: Chemoprevention with triphenylselenonium chloride in selenium-deficient rats. Cancer Res 2000;60:2882-2886.
24. Redman C, Scott JA, Baines AT, et al. : Inhibitory effect of se-lenomethionine on the growth of three selected human tumor cell lines. Cancer Lett 1998;125:103-110.
25. Smith ML, Chen IT, Zhan Q, O'Connor PM, Fornace PM, For-nace AJ Jr: Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene 1995;10:1053-1059.
26. Smith ML, Ford JM, Hollander MC, et al. : p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes. Mol Cell Biol 2000;20:3705- 3714.
27. Seo YR, Fishel ML, Amundson S, Kelly MR, Smith ML: Implication of p53 in base excision DNA repair: in vivo evidence. Oncogene 2002;21:731-737.
28. Zhou J, Ahn J, Wilson SH, Prives C: A role for p53 in base excision repair. EMBO J 2001;20:914-923.
29. Offer H, Wolkowicz R, Matas D, Blumenstein S, Livneh Z, Rotter V: Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery. FEBS Lett 1999;450:197-204.
30. Offer H, Erez N, Zurer I, et al. : The onset of p53-dependent DNA repair or apoptosis is determined by the level of accumulated damaged DNA. Carcinogenesis 2002;23:1025-1032.
31. Seeberg E, Eide L, Bjorås M: The base excision repair pathway. Trans Biochem Sci 1995;20:391-397.